( en | de | ru )

 

Disambiguation of "Sniderman, A."

Author of the publication

copydeleteadd this publication to your clipboard
Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis.

, , , and . Atheroscler Suppl, 5 (2): 19--24 (May 2004)
DOI: 10.1016/j.atherosclerosissup.2004.03.005

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

R. A. A. Bowler

°Ake °Akerström

Mohamed A A Anndif

Eltohamy A A Yousef

A Rukhadze

 

Other publications of authors with the same name

Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses., , , , , and . J Biol Chem, 260 (8): 5067--5072 (April 1985)Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis., , , and . Atheroscler Suppl, 5 (2): 19--24 (May 2004)Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment., , , , , , and . Lancet, 361 (9359): 777--780 (March 2003)How, when, and why to use apolipoprotein B in clinical practice.. Am J Cardiol, (October 2002)Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk., , , , , and . Am J Cardiol, 91 (10): 1173--1177 (May 2003)Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS)., , , , , and . Circulation, 108 (19): 2312--2316 (November 2003)Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel., , , , , , , , , and 20 other author(s). J Intern Med, 259 (3): 247--258 (March 2006)